Allen & Overy has advised Charterhouse Capital Partners LLP (Charterhouse), a leading European private equity firm, on the divestment of Tarsus, a global B2B media and events business, to Informa PLC (Informa), a leading international exhibitions, events, information services and scholarly research group, for an enterprise value of c. USD940 million. The consideration comprises a mixture of cash and new Informa shares.
Tarsus is one of the most well-known and respected names in the B2B events industry. It operates in the US, Europe and Asia across a diverse range of sectors including Automotive & Transport, Sustainability, Technology and Healthcare and with a portfolio of over 160 live and online B2B event brands.
The Allen & Overy team was led by private equity partner Gordon Milne and corporate partner Claire Coppel, with support from Tina Barazandeh-Nejad (Senior Associate), Felix Jiang, Kiuree Kim, Nina Gogic, Caitlin Smith, and Poppy Kevelighan (Associates). The team also included partners and lawyers from various practice areas and offices, including antitrust, banking, employment, intellectual property, pensions, real estate, tax and US securities.
Gordon Milne commented: “Advising Charterhouse on this significant transaction demonstrates the strength and depth of our private equity and M&A capabilities, as well as our ability to deliver cross-border deals involving multiple jurisdictions and stakeholders. The Tarsus group is a highly successful and innovative business, and we wish it and Informa all the best for the future.”
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
The advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
